相关实验视频

Updated: Jul 4, 2025

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

一个微血栓驱动的固定点裂解纳米系统,通过抑制铁灭,防止血栓溶解后的复发

Mengjuan Sun¹, Chang Liu¹, Ji Liu¹

¹State Key Laboratory of Natural Medicines, China Pharmaceutical University, 639 Long Mian Da Dao, Nanjing 211198, China; Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, 639 Long Mian Da Dao, Nanjing 211198, China.

Journal of controlled release : official journal of the Controlled Release Society

|February 3, 2024

概括

一个新的Fer-1/uPA@pep-CREKA-Lipo系统通过向血块来增强血栓溶解. 这种创新方法改善了血栓微环境,减少了缺血-再输液损伤,提供了更安全,更有效的心血管疾病治疗.

科学领域:

生物医学工程生物医学工程
心血管研究研究心血管研究
药物输送系统药物输送系统

背景情况:

血栓诱导的心血管疾病对健康构成重大风险.
目前的泌尿酸酶等离子激素激活剂 (uPA) 治疗有局限性,包括短半衰期,低血栓向性和全身出血风险.
血栓溶解干预可以加剧炎症并损害血栓部位的内皮功能.

研究的目的:

开发一种先进的药物输送系统,以实现精确高效的血栓分析.
为了增强血栓微环境并减轻缺血-再输液损伤.
为了克服传统的血栓溶解疗法的局限性.

主要方法:

铁-1/uPA@pep-CREKA-Lipo (Fu@pep-CLipo) 纳米颗粒的开发.
使用Cys-Arg-Glu-Lys-Ala (CREKA) 用于纤维素向.
结合血素可切割 (pep) 进行向的uPA释放.
封装Fer-1用于反应性氧物种 (ROS) 清理.

主要成果:

@pep-CLipo表现出异常的血栓向能力.
该系统通过增强的血栓微环境实现了精确和高效的血栓溶解.
铁-1 含量显著减少了 ROS,改善了微环境并减轻了缺血-再输液损伤.
观察到对eNOS蛋白表达和抑制炎症因子 (TNF-α,IL-6) 的积极影响.

结论:

Fu@pep-CLipo提供了一种有前途的针对性血栓溶解策略.
这种创新系统有效地增强了血栓微环境,并减少了相关的伤害.
精确血栓溶解和微环境调制的双重作用在心血管疾病治疗中取得了重大进展.

关键词:

克里卡脂质体的脂质体改善血栓的微环境.站点定向释放是指导释放的这种药物对血栓素有反应.血栓向向的目标

更多相关视频

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...